About CEVHAP

The Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) was established
as a multidisciplinary body to advocate for public policy reforms that aim to reduce
the burden of viral hepatitis in Asia-Pacific.

As a non-profit organisation, incorporated in Singapore in October 2010, CEVHAP
is the first organisation to be established within the region that is dedicated to public
policy reform, with particular focus on building capacity within the viral hepatitis
healthcare sectors, and promoting greater education and awareness about viral
hepatitis across all sectors.

 

FaLang translation system by Faboba

 CEVHAP_Strategy_2017-2021_Image.jpg

>> CEVHAP Strategy 2017-2021

 

nohep.logo_horizontal.jpg

NOhep is a global, grassroots movement aimed at bringing all stakeholders together to eliminate viral hepatitis by 2030. It has been developed to create global awareness of the disease, similar to the red ribbon for HIV/AIDS, and was launched in 2016. NOhep firmly positions itself at the forefront of the elimination conversation, showcasing exemplary leadership, fostering on-the-ground innovative solutions and taking action to support the policy changes needed to eliminate this cancer-causing illness by 2030. Being a part of NOhep means being part of the solution. (To find out more about the development of this exciting initiative, watch this short video: https://youtu.be/Oer-rGwnKZU ) 

>> FAST FACTS
Viral Hepatitis
  Globally, 2 billion people have been
infected with hepatitis B virus, with an
estimated 600,000 dying each year . . .
  The number of people with chronic
hepatitis C and more advanced liver
disease or cirrhosis, is projected to
increase by 38% between 2006 and 2015
unless the number of people being
treated increases substantially.
  There is no vaccine for hepatitis C but
approximately 80% of patients who are
able to complete recommended
treatment, are cured . . .
>> FEATURED VIDEOS 
Why hepatitis policy matters - the story of Baltazar Lucas  
 
Video What are the dangers of viral #hepatitis? Hear what #CEVHAP Chair Prof Ding-Shinn Chen had to say to the Wall Street Journal.
  
A Message from DS Chen
Chairman, CEVHAP

 

Connect with usconnect with CEVHAP